#United States #New York #Northwell Health #Lumonus #Smarter Radiation Oncology

Lumonus and Smarter Radiation Oncology: A Revolutionary Partnership in Cancer Care

In a groundbreaking collaboration, Lumonus, a healthcare technology innovator, has signed a multi-year licensing agreement with Smarter Radiation Oncology® (SRO), an initiative incubated by Northwell Health. This partnership aims to bring evidence-based treatment protocols to cancer centers across the United States, enhancing the quality and consistency of radiation therapy.

Revolutionizing Cancer Treatment

Lumonus is known for its AI-driven platform that seeks to transform cancer care delivery. By integrating SRO's proven directives into its platform, Lumonus will simplify oncology workflows and improve patient outcomes. This integration promises to automate several administrative tasks that healthcare providers face, including clinical preparation and documentation, which will free up clinicians to focus on their patients.

The SRO model, developed by Northwell Health—the largest health system in New York—has demonstrated the ability to standardize nearly 90% of its radiation therapy treatments. This systematic approach minimizes variability in treatment, significantly reduces clinician workload, and enhances safety and efficiency.

Evidence-Based Directives

The core objective of this partnership is to broaden access to best-practice protocols for delivering high-quality radiation therapy. The SRO model sets clear prescribing standards, allowing for standardized treatment across multiple cancer centers. Research has shown that SRO's directives can elevate care quality by fostering consistency, improving safety measures, and streamlining operational efficiencies.

Keith Hansen, CEO of Lumonus, emphasized the tremendous potential of this partnership: "By collaborating with SRO, we're not merely integrating their directives into our platform; we’re enabling cancer centers to provide safer, more efficient care directly informed by the latest clinical evidence."

The Impact of AI in Oncology

With Lumonus’ innovative AI Physician platform, clinicians will now have access to validated, real-world prescribing standards at the point of care. This immediate access to effective guidelines will facilitate quicker, safer, and more equitable treatment decisions for patients. A commitment to improving patient care is at the heart of this initiative, reflecting a shared vision between Lumonus and SRO for the future of radiation oncology.

Louis Potters, MD, Chair of Radiation Medicine at Northwell Health, commented on the significance of making these high standards more widely available. He stated, "Smarter Radiation Oncology represents years of dedication to improving quality in radiation therapy across our network. Through this new agreement with Lumonus, we can now extend these advancements to the global oncology community."

About Lumonus and Smarter Radiation Oncology

Lumonus

Lumonus is at the forefront of innovation in cancer care, built on its AI-native digital oncology platform that automates essential workflows in oncology. It operates in the United States, Australia, and Europe, working alongside leading cancer centers to enhance care delivery.

Smarter Radiation Oncology

SRO has served as Northwell Health's evidence-based model for delivering radiation therapy for the past 15 years. It is dedicated to ensuring every patient receives high-quality care regardless of their location or center. Its directives have a measurable impact on treatment safety and operational efficiency, helping to transform complex radiation oncology practices into systematic, evidence-based care delivery.

In an era where healthcare technology is rapidly evolving, partnerships like that of Lumonus and SRO exemplify the shift towards a more standardized, patient-focused approach to cancer treatment.